Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR).
Sci Rep
; 5: 16331, 2015 Nov 17.
Article
in En
| MEDLINE
| ID: mdl-26573509
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Ras Proteins
/
Taxoids
/
Erlotinib Hydrochloride
/
Lung Neoplasms
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Sci Rep
Year:
2015
Document type:
Article
Affiliation country:
Italy